KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Gains from Investment Securities (2016 - 2025)

Nu Skin Enterprises' Gains from Investment Securities history spans 11 years, with the latest figure at $483000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $483000.0; the TTM value through Dec 2025 reached $2.2 million, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
  • Gains from Investment Securities for Q4 2025 was $483000.0 at Nu Skin Enterprises, down from $635000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $28.1 million in Q1 2025 and bottomed at -$27.0 million in Q2 2025.
  • The 5-year median for Gains from Investment Securities is $483000.0 (2021), against an average of $485578.9.
  • The largest YoY upside for Gains from Investment Securities was 3479.62% in 2025 against a maximum downside of 3581.29% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $462000.0 in 2021, then rose by 12.12% to $518000.0 in 2022, then skyrocketed by 57.53% to $816000.0 in 2023, then plummeted by 291.18% to -$1.6 million in 2024, then soared by 130.96% to $483000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUS's Gains from Investment Securities are $483000.0 (Q4 2025), $635000.0 (Q3 2025), and -$27.0 million (Q2 2025).